Non-invasive index
|
AUC (95% CI)
|
Difference between areas (95% CI)*
|
P*
|
---|
Prominent fibrosis
| | | |
HB-F (training)
|
0.810 (0.751, 0.861)
| | |
HB-F (verification)
|
0.797 (0.737, 0.849)
| | |
FIB-4
|
0.772 (0.709, 0.826)
|
0.0255 (-0.0236, 0.0746)
|
0.3087
|
Fibroindex
|
0.767 (0.704, 0.822)
|
0.0301 (-0.0298, 0.0899)
|
0.3251
|
ARPI
|
0.753 (0.689, 0.810)
|
0.0439 (-0.0302, 0.1180)
|
0.2454
|
AAR
|
0.630 (0.561, 0.696)
|
0.1670 (0.0947, 0.2390)
|
< 0.0001
|
FI
|
0.724 (0.659, 0.784)
|
0.0728 (0.0093, 0.1360)
|
0.0246
|
Cirrhosis
| | | |
HB-F (training)
|
0.799 (0.739, 0.851)
| | |
HB-F (verification)
|
0.757 (0.694, 0813)
| | |
FIB-4
|
0.727 (0.662, 0.786)
|
0.0297 (-0.0223, 0.0818)
|
0.2624
|
Fibroindex
|
0.722 (0.656, 0.781)
|
0.0351 (-0.0320, 0.1020)
|
0.3054
|
ARPI
|
0.698 (0.631, 0.759)
|
0.0589 (-0.0244, 0.1400)
|
0.1556
|
AAR
|
0.636 (0.568, 0.701)
|
0.1210 (0.0470, 0.1950)
|
0.0013
|
FI
|
0.717 (0.651, 0.777)
|
0.0403 (-0.0283, 0.1090)
|
0.2497
|
- *Comparison between the AUC of HB-F (verification cohort) and those of the other scoring methods.